跳至主要内容
临床试验/ACTRN12624000276550
ACTRN12624000276550尚未招募1 期

Safety and efficacy of Eucalypt sap resin for inflammatory skin conditions and wound care in adults – An exploratory case series

Integria Healthcare (Australia) Pty Ltd.0 个研究点目标入组 60 人开始时间: 2024年3月18日最近更新:

试验速览

阶段
1 期
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • Adult males and females
  • Presence of inflammatory skin condition or wound

排除标准

  • - Pregnant, planning pregnancy or breastfeeding
  • - Any clinically relevant abnormal findings which, in the opinion of the Investigators may put the participant at risk of adverse events due to participation in clinical trial.
  • - Use of any topical or oral anti-microbial, anti-fungal, anti-acne, or steroid medicated treatments in the previous 3 days

研究者

相似试验